$0.9088
-0.0007-0.08%
Last update: Nov 9, 6:58 PM
NovaBridge Biosciences
NBPNASDAQ
The average analyst price target for NovaBridge Biosciences is $9, 867.7% above the current price. The one analyst covering it rates it Buy. The latest change came on Feb 6, 2026, when HC Wainwright & Co. raised its price target on NovaBridge Biosciences from $7 to $9 and kept a Buy rating.
Price Target Range — 3 Quarters
Analyst Consensus — 1 Analysts
Rating Trend — Last 9 Months
